TrademarkDir
EFFIMUNE
LIVE

Serial Number

79109143

Owner

EFFIMUNE

Attorney

James R. Robinson

Filing Date

Dec 23, 2011

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

EFFIMUNE Trademark

Serial Number: 79109143 • Registration: 4266293

EFFIMUNE is a trademark filed by EFFIMUNE on December 23, 2011. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

EFFIMUNE

1 rue Gaston Veil

Entity Type: 99

TcL PHARMA (2 trademarks)

21 rue de Lanouë Bras de Fer

Entity Type: 99

Trademark Details

Filing Date

December 23, 2011

Registration Date

January 1, 2013

Published for Opposition

October 16, 2012

Cancellation Date

December 23, 2021

Goods & Services

Pharmaceutical preparations, namely, immunomodulators for use in transplantation autoimmune disease and oncology; chemical-pharmaceutical preparations, namely, immunomodulators for use in transplantation autoimmune disease and oncology; diagnostic goods for medical use, namely, medical diagnostic reagents, radioisotope markers for diagnostic use, diagnostic preparations for medical use; chemical reagents for medical use, namely, biomarkers, surgical implants comprising living tissue, genes, and biomaterials for medical use

Pharmacy advice, namely, pharmaceutical advice; hospital services for persons with physical and/or cognitive disabilities or impairments; health care services

Chemical and biological analyses, immunological analysis, research and development of new products for third parties, research in biotechnology, in biology, in bacteriology, in chemistry

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jul 17, 2022 DENC
DEATH OF INTERNATIONAL REGISTRATION
Jul 16, 2022 DETH
NEW REPRESENTATIVE AT IB RECEIVED
Feb 8, 2019 NREP
TOTAL INVALIDATION PROCESSED BY THE IB
Feb 23, 2018 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jan 30, 2018 INTS
INVALIDATION PROCESSED
Jan 30, 2018 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 22, 2018 INTR
CANCELLED SECTION 18-TOTAL
May 22, 2017 C18.
CANCELLATION TERMINATED NO. 999999
May 22, 2017 CANT
CANCELLATION GRANTED NO. 999999
May 6, 2017 CANG
CANCELLATION INSTITUTED NO. 999999
Jan 20, 2017 PETC
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 22, 2013 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 30, 2013 FICS
FINAL DISPOSITION PROCESSED
Aug 30, 2013 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 1, 2013 FICR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Mar 16, 2013 ADCH
REGISTERED-PRINCIPAL REGISTER
Jan 1, 2013 R.PR
NOTIFICATION PROCESSED BY IB
Dec 10, 2012 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 16, 2012 NPUB
PUBLISHED FOR OPPOSITION
Oct 16, 2012 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 26, 2012 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 26, 2012 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 26, 2012 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 13, 2012 PREV
ASSIGNED TO LIE
Sep 13, 2012 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 4, 2012 CNSA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 31, 2012 TCCA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 31, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 31, 2012 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 31, 2012 TROA
REFUSAL PROCESSED BY IB
Apr 27, 2012 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 10, 2012 RFCS
REFUSAL PROCESSED BY MPU
Apr 10, 2012 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 30, 2012 RFCR
NON-FINAL ACTION WRITTEN
Mar 29, 2012 CNRT
ASSIGNED TO EXAMINER
Mar 29, 2012 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 6, 2012 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 2, 2012 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 1, 2012 REPR

Related Trademarks

More from this Owner

TCL PHARMA logo

TCL PHARMA